Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 5
2004 3
2005 4
2006 3
2007 9
2008 2
2009 1
2010 9
2011 10
2012 10
2013 13
2014 14
2015 16
2016 9
2017 15
2018 14
2019 15
2020 11
2021 18
2022 17
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Radical hospitality: Innovative programming to build community and meet the needs of people who use drugs at a government-sanctioned overdose prevention site in San Francisco, California.
Wenger LD, Morris T, Knight KR, Megerian CE, Davidson PJ, Suen LW, Majano V, Lambdin BH, Kral AH. Wenger LD, et al. Among authors: kral ah. Int J Drug Policy. 2024 Apr;126:104366. doi: 10.1016/j.drugpo.2024.104366. Epub 2024 Mar 16. Int J Drug Policy. 2024. PMID: 38492432 Free article.
Funding and Delivery of Syringe Services Programs in the United States, 2022.
Facente SN, Humphrey JL, Akiba C, Patel SV, Wenger LD, Tookes H, Bluthenthal RN, LaKosky P, Prohaska S, Morris T, Kral AH, Lambdin BH. Facente SN, et al. Among authors: kral ah. Am J Public Health. 2024 Apr;114(4):435-443. doi: 10.2105/AJPH.2024.307583. Am J Public Health. 2024. PMID: 38478864 Free PMC article.
Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial.
Lambdin BH, Bluthenthal RN, Garner BR, Wenger LD, Browne EN, Morris T, Ongais L, Megerian CE, Kral AH. Lambdin BH, et al. Among authors: kral ah. Implement Sci. 2024 Feb 28;19(1):22. doi: 10.1186/s13012-024-01354-y. Implement Sci. 2024. PMID: 38419058 Free PMC article. Clinical Trial.
'New evidence' for Syringe Services Programs? A call for rigor and skepticism.
Lambdin BH, Bluthenthal RN, Humphrey JL, LaKosky P, Prohaska S, Kral AH. Lambdin BH, et al. Among authors: kral ah. Int J Drug Policy. 2023 Nov;121:104107. doi: 10.1016/j.drugpo.2023.104107. Epub 2023 Aug 1. Int J Drug Policy. 2023. PMID: 37996217 Free article. No abstract available.
Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
McLaren PJ, Porreca I, Iaconis G, Mok HP, Mukhopadhyay S, Karakoc E, Cristinelli S, Pomilla C, Bartha I, Thorball CW, Tough RH, Angelino P, Kiar CS, Carstensen T, Fatumo S, Porter T, Jarvis I, Skarnes WC, Bassett A, DeGorter MK, Sathya Moorthy MP, Tuff JF, Kim EY, Walter M, Simons LM, Bashirova A, Buchbinder S, Carrington M, Cossarizza A, De Luca A, Goedert JJ, Goldstein DB, Haas DW, Herbeck JT, Johnson EO, Kaleebu P, Kilembe W, Kirk GD, Kootstra NA, Kral AH, Lambotte O, Luo M, Mallal S, Martinez-Picado J, Meyer L, Miro JM, Moodley P, Motala AA, Mullins JI, Nam K, Obel N, Pirie F, Plummer FA, Poli G, Price MA, Rauch A, Theodorou I, Trkola A, Walker BD, Winkler CA, Zagury JF, Montgomery SB, Ciuffi A, Hultquist JF, Wolinsky SM, Dougan G, Lever AML, Gurdasani D, Groom H, Sandhu MS, Fellay J. McLaren PJ, et al. Among authors: kral ah. Nature. 2023 Sep;621(7979):E42. doi: 10.1038/s41586-023-06591-7. Nature. 2023. PMID: 37670157 No abstract available.
185 results